A Research Study to Test Safety, Tolerability, and Immunogenicity of a Recombinant Hepatitis B Vaccine Manufactured With an Upgrade to the Production Process (V232-054)

NCT00489099 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

860

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis B Infection

Interventions

BIOLOGICAL: V232 Modified Process Hepatitis B Vaccine: Lot A
BIOLOGICAL: V232 Modified Process Hepatitis B Vaccine: Lot B
BIOLOGICAL: V232 Modified Process Hepatitis B Vaccine: Lot C
BIOLOGICAL: V232 Current Process Hepatitis B Vaccine

Sponsor

Merck Sharp & Dohme LLC